Document Detail

Protective role of magnesium in cardiovascular diseases: a review.
MedLine Citation:
PMID:  12349904     Owner:  NLM     Status:  MEDLINE    
A considerable number of experimental, epidemiological and clinical studies are now available which point to an important role of Mg2+ in the etiology of cardiovascular pathology. In human subjects, hypomagnesemia is often associated with an imbalance of electrolytes such as Na+, K+ and Ca2+. Abnormal dietary deficiency of Mg2+ as well as abnormalities in Mg2+ metabolism play important roles in different types of heart diseases such as ischemic heart disease, congestive heart failure, sudden cardiac death, atheroscelerosis, a number of cardiac arrhythmias and ventricular complications in diabetes mellitus. Mg2+ deficiency results in progressive vasoconstriction of the coronary vessels leading to a marked reduction in oxygen and nutrient delivery to the cardiac myocytes. Numerous experimental and clinical data have suggested that Mg2+ deficiency can induce elevation of intracellular Ca2+ concentrations, formation of oxygen radicals, proinflammatory agents and growth factors and changes in membrane perrmeability and transport processes in cardiac cells. The opposing effects of Mg2+ and Ca2+ on myocardial contractility may be due to the competition between Mg2+ and Ca2+ for the same binding sites on key myocardial contractile proteins such as troponin C, myosin and actin. Stimulants, for example, catecholamines can evoke marked Mg2+ efflux which appears to be associated with a concomitant increase in the force of contraction of the heart. It has been suggested that Mg2+ efflux may be linked to the Ca2+ signalling pathway. Depletion of Mg2+ by alcohol in cardiac cells causes an increase in intracellular Ca2+, leading to coronary artery vasospasm, arrhythmias, ischemic damage and cardiac failure. Hypomagnesemia is commonly associated with hypokalemia and occurs in patients with hypertension or myocardial infarction as well as in chronic alcoholism. The inability of the senescent myocardium to respond to ischemic stress could be due to several reasons. Mg2+ supplemented K+ cardioplegia modulates Ca2+ accumulation and is directly involved in the mechanisms leading to enhanced post ischemic functional recovery in the aged myocardium following ischemia. While many of these mechanisms remain controversial and in some cases speculative, the beneficial effects related to consequences of Mg2+ supplementation are apparent. Further research are needed for the incorporation of these findings toward the development of novel myocardial protective role of Mg2+ to reduce morbidity and mortality of patients suffering from a variety of cardiac diseases.
Sajal Chakraborti; Tapati Chakraborti; Malay Mandal; Amritlal Mandal; Sudip Das; Samarendranath Ghosh
Related Documents :
24954194 - Pneumonia, thrombosis and vascular disease.
23601374 - Panmedullary edema with inferior olivary hypertrophy in bilateral medial medullary infa...
1269104 - Experimental myocardial infarction in the cat. i. reversible decline in contractility o...
23474664 - Management of ischemic stroke in the hyperacute phas.
18487534 - Right atrial cavotricuspid isthmus: anatomic characterization with multi-detector row ct.
25267584 - Associations of electrocardiographic p-wave characteristics with left atrial structure,...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Molecular and cellular biochemistry     Volume:  238     ISSN:  0300-8177     ISO Abbreviation:  Mol. Cell. Biochem.     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-27     Completed Date:  2003-09-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0364456     Medline TA:  Mol Cell Biochem     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  163-79     Citation Subset:  IM    
Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / genetics,  metabolism*,  pathology*
Ion Channel Gating
Magnesium / metabolism*
Magnesium Deficiency
Oxidants / metabolism
Protective Agents / metabolism*
Signal Transduction
Reg. No./Substance:
0/Oxidants; 0/Protective Agents; 7439-95-4/Magnesium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Protective effects of antioxidative serotonin derivatives isolated from safflower against postischem...
Next Document:  Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutat...